The Conversation (0)
True Leaf Medicine International issued an update to shareholders on the development of its cannabis cultivation and production facility, which remains on schedule to be completed by the fall.
True Leaf Medicine International (CSE:MJ) issued an update to shareholders on the development of its cannabis cultivation and production facility, which remains on schedule to be completed by the fall.
As quoted in the press release:
The first phase of the project includes a two-storey 9,000 square foot central hub for the initial grow area, laboratory services, whole-plant extraction, and the production of therapeutic cannabis products, followed by a 16,000 square foot wing for cannabis cultivation. The facilities, being built in Lumby, British Columbia, will be a hub for the development of the company’s medicinal cannabis products.
Deep utilities, trenching, and other civil works began in early July and the formwork and structural steel construction of the administration area was completed by mid-June. Crews are now installing the roof and first floor decking, leading up to completion of the building envelope by end of August.
“Our build team continues to make significant progress on True Leaf Campus,” said Darcy Bomford, Founder and Chief Executive Officer of True Leaf. “This means True Leaf is getting closer to its inspection by Health Canada and nearing the final milestone of receiving our license to produce cannabis. We’re eager to develop a line of medicinal cannabis products and bring it to market.”
As quoted in the press release.
Source: globenewswire.com
